miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma

Abstract

These results show that miR-622 acts as a tumor suppressor in thyroid cancer, at least in part, via targeting VEGFA, and suggest that miR-622 may serves as a potential target for treatment of thyroid cancer patients.